Naloxone Hydrochloride
- Product NDC
- 67457-645
- 11-digit product format
- 674570645
- Labeler code
- 67457
- Product ID
- 67457-645_ae19fec7-aac8-4fbe-a2aa-ba18a3fe5c9e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- naloxone hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA204997
- Marketing category
- ANDA
- Marketing start
- 2020-01-24
- Marketing end
- 0000-00-00
- Substance
- NALOXONE HYDROCHLORIDE
- Active strength
- 0 mg/mL
- Pharmacologic classes
- Opioid Antagonist [EPC],Opioid Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67457-645 | NALOXONE HYDROCHLORIDE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] | 2 | Legacy NDC | 20210427_5adbf891-4d73-4026-98b1-174783d68c9a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-645-02 | 67457064502 | 10 VIAL, SINGLE-DOSE in 1 CARTON (67457-645-02) > 1 mL in 1 VIAL, SINGLE-DOSE (67457-645-00) | 2020-01-24 | 0000-00-00 | No | No | Current |